Direct targeting of oncogenic RAS mutants with a tumor-specific cytosol-penetrating antibody inhibits RAS mutant–driven tumor growth

Oncogenic RAS mutant (RAS(MUT)) proteins have been considered undruggable via conventional antibody regimens owing to the intracellular location restricting conventional-antibody accessibility. Here, we report a pan-RAS–targeting IgG antibody, inRas37, which directly targets the intracellularly acti...

Descripción completa

Detalles Bibliográficos
Autores principales: Shin, Seung-Min, Kim, Ji-Sun, Park, Seong-Wook, Jun, Sei-Yong, Kweon, Hye-Jin, Choi, Dong-Ki, Lee, Dakeun, Cho, Yong Beom, Kim, Yong-Sung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2020
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6962039/
https://www.ncbi.nlm.nih.gov/pubmed/31998840
http://dx.doi.org/10.1126/sciadv.aay2174

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6962039/
https://www.ncbi.nlm.nih.gov/pubmed/31998840
http://dx.doi.org/10.1126/sciadv.aay2174

Ejemplares similares